EVGN logo

EVGN
Evogene Ltd

3,718
Mkt Cap
$7.92M
Volume
66,560.00
52W High
$2.42
52W Low
$0.72
PE Ratio
-0.69
EVGN Fundamentals
Price
$0.8005
Prev Close
$0.7952
Open
$0.783
50D MA
$0.8568
Beta
0.84
Avg. Volume
181,455.60
EPS (Annual)
-$1.08
P/B
-85.07
Rev/Employee
$74,096.15
$9.93
Loading...
Loading...
News
all
press releases
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification PR Newswire REHOVOT, Israel, April 2, 2026 REHOVOT, Israel, April 2...
PR Newswire·17d ago
News Placeholder
More News
News Placeholder
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification PR Newswire REHOVOT, Israel, April 2, 2026 REHOVOT, Israel, April 2...
PR Newswire·17d ago
News Placeholder
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock Casterra Announces Successful Commercial...
PR Newswire·19d ago
News Placeholder
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock Casterra Announces Successful Commercial...
PR Newswire·19d ago
News Placeholder
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 PR Newswire REHOVOT, Israel, March 9...
PR Newswire·1mo ago
News Placeholder
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 PR Newswire REHOVOT, Israel, March 9...
PR Newswire·1mo ago
News Placeholder
Evogene Earnings Review: Q4 Summary
read more...
Benzinga·2mo ago
News Placeholder
Evogene Earnings Review: Q4 Summary
read more...
Benzinga·2mo ago
News Placeholder
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results Evogene Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire REHOVOT, Israel, March 5, 2026 Conference call and...
PR Newswire·2mo ago
News Placeholder
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results Evogene Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire REHOVOT, Israel, March 5, 2026 Conference call and...
PR Newswire·2mo ago
<
1
2
...
>

Latest EVGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.